In the current session, Super Micro Computer Inc. (NASDAQ:SMCI) is trading at $29.91, after a 0.35% drop. Over the past month, the stock fell by 12.10%, and in the past year, by 8.27%. With performance like this, long-term shareholders are…
If you’ve been watching crypto recently, you may have noticed something unusual. The headlines are quieter. Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) prices are moving in relatively narrow ranges, and volatility has slowed compared to past cycles. For casual…
President Donald Trump told The New York Times he has decided on the next Federal Reserve Chair but won’t disclose the name, while Treasury Secretary Scott Bessent said rate cuts are “the only ingredient missing” for stronger economic growth. Trump…
President Donald Trump may have grabbed headlines with buyback threats and a proposed $1.5 trillion defense budget, but for investors, the real question is simpler: which defense stock actually looks best priced if spending really accelerates? With policy noise largely…
Micron Technology Inc. (NASDAQ:MU) is riding an AI-fueled memory squeeze, with JP Morgan saying demand for DRAM, especially HBM, should continue to outstrip supply past 2026, keeping pricing firm and reinforcing its bullish stance on the stock. JP Morgan analyst…
Gold has spent years being treated as insurance — useful, but rarely exciting. Danny Moses, best known as one of the traders featured in The Big Short, thinks that framing is already outdated. In an exclusive interview with Benzinga, Moses…
Enliven Therapeutics Inc. (NASDAQ:ELVN) stock is trading higher on Thursday, with a session volume of 6.61 million compared to the average volume of 631.52 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared encouraging initial data from…
MoonLake Immunotherapeutics (NASDAQ:MLTX) on Thursday received U.S. Food and Drug Administration (FDA) feedback regarding the clinical evidence strategy for Sonelokimab (SLK) in Hidradenitis Suppurativa (HS), based on the Type B meeting requested by MoonLake. SLK was associated with significant improvements…
Acrivon Therapeutics Inc. (NASDAQ:ACRV) on Thursday shared updates regarding the Phase 2 ACR-368 program and initial clinical data from the ACR-2316 Phase 1 study. ACR-368 Data In Arm 1 of the ACR-368 Phase 2b registrational-intent trial in endometrial cancer, an…
Sigma Lithium Corporation (NASDAQ:SGML) stock fell Thursday after Bank of America Securities (BofA) turned more bearish, warning that unresolved operational delays and liquidity uncertainty are overshadowing any rebound in lithium prices and limiting the company’s ability to deliver meaningful near-term…